Cargando…
Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Psychiatric Pharmacists
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583257/ https://www.ncbi.nlm.nih.gov/pubmed/37860586 http://dx.doi.org/10.9740/mhc.2023.08.183 |
_version_ | 1785122512549445632 |
---|---|
author | Caballero, Joshua Xu, Jianing Hall, Daniel B. Chen, Xianyan Young, Henry N. |
author_facet | Caballero, Joshua Xu, Jianing Hall, Daniel B. Chen, Xianyan Young, Henry N. |
author_sort | Caballero, Joshua |
collection | PubMed |
description | INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial and ethnic differences among LAI antipsychotic use. Secondary objectives were to identify if discontinuation rates differed between agents and by race or ethnicity. METHODS: International Classification of Diseases, 10th edition (ICD-10) codes were used to identify patients with schizophrenia and related disorders (18-64 years) who received an LAI antipsychotic between 2016 and 2020 using Merative Multi-State Medicaid databases. Using National Drug Code numbers for LAI antipsychotics, pharmacy claims were identified and data analyzed. Cochran-Mantel-Haenszel tests and odds ratio estimators were used to investigate conditional association between race or ethnicity and medication, while controlling for age, sex, health plan, and prescription year. Kaplan-Meier survival curves were examined, and stratified log-rank tests were conducted to compare the time until discontinuation distributions by race or ethnicity. RESULTS: The analysis included 37 712 patients. Blacks received an LAI first-generation antipsychotic more often than Whites (OR: 1.64, 95% CI: [1.56, 1.73], Hispanics (OR: 1.46, 95% CI: [1.21, 1.75]) and others (OR: 1.44, 95% CI: [1.20, 1.73]). Aside from fluphenazine decanoate showing earlier discontinuation rates for Whites over Blacks (P = .02), no significant differences in discontinuation across race or ethnicity were identified. DISCUSSION: Despite no significant differences in second-generation antipsychotic LAI discontinuation rates between Blacks and other racial or ethnic groups, Blacks received second-generation antipsychotic LAIs significantly less often than other groups. Further studies are needed to determine why differences may be occurring. |
format | Online Article Text |
id | pubmed-10583257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association of Psychiatric Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-105832572023-10-19 Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data Caballero, Joshua Xu, Jianing Hall, Daniel B. Chen, Xianyan Young, Henry N. Ment Health Clin Original Research INTRODUCTION: In general, racial and ethnic differences exist in antipsychotic prescription practices. However, little is known about such differences between individual long-acting injectable (LAI) antipsychotic formulations, specifically. This study's primary objective was to determine racial and ethnic differences among LAI antipsychotic use. Secondary objectives were to identify if discontinuation rates differed between agents and by race or ethnicity. METHODS: International Classification of Diseases, 10th edition (ICD-10) codes were used to identify patients with schizophrenia and related disorders (18-64 years) who received an LAI antipsychotic between 2016 and 2020 using Merative Multi-State Medicaid databases. Using National Drug Code numbers for LAI antipsychotics, pharmacy claims were identified and data analyzed. Cochran-Mantel-Haenszel tests and odds ratio estimators were used to investigate conditional association between race or ethnicity and medication, while controlling for age, sex, health plan, and prescription year. Kaplan-Meier survival curves were examined, and stratified log-rank tests were conducted to compare the time until discontinuation distributions by race or ethnicity. RESULTS: The analysis included 37 712 patients. Blacks received an LAI first-generation antipsychotic more often than Whites (OR: 1.64, 95% CI: [1.56, 1.73], Hispanics (OR: 1.46, 95% CI: [1.21, 1.75]) and others (OR: 1.44, 95% CI: [1.20, 1.73]). Aside from fluphenazine decanoate showing earlier discontinuation rates for Whites over Blacks (P = .02), no significant differences in discontinuation across race or ethnicity were identified. DISCUSSION: Despite no significant differences in second-generation antipsychotic LAI discontinuation rates between Blacks and other racial or ethnic groups, Blacks received second-generation antipsychotic LAIs significantly less often than other groups. Further studies are needed to determine why differences may be occurring. American Association of Psychiatric Pharmacists 2023-08-07 /pmc/articles/PMC10583257/ /pubmed/37860586 http://dx.doi.org/10.9740/mhc.2023.08.183 Text en © 2023 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Caballero, Joshua Xu, Jianing Hall, Daniel B. Chen, Xianyan Young, Henry N. Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title | Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title_full | Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title_fullStr | Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title_full_unstemmed | Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title_short | Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data |
title_sort | racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using medicaid claims data |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583257/ https://www.ncbi.nlm.nih.gov/pubmed/37860586 http://dx.doi.org/10.9740/mhc.2023.08.183 |
work_keys_str_mv | AT caballerojoshua racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata AT xujianing racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata AT halldanielb racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata AT chenxianyan racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata AT younghenryn racialandethnicdifferencesinpatternsofuseanddiscontinuationoflongactinginjectableantipsychoticsusingmedicaidclaimsdata |